Unnamed: 0,title,date,stock,sentiment
1370316.0,"The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",2020-05-21 08:01:00-04:00,WST,neutral
1370317.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,WST,positive
1370318.0,S&P Dow Jones Indices 'West Pharmaceutical Services Set to Join S&P 500; Physicians Realty Trust to Join S&P MidCap 400; Helmerich & Payne to Join S&P SmallCap 600',2020-05-18 17:19:00-04:00,WST,positive
1370319.0,Stocks That Hit 52-Week Highs On Monday,2020-05-18 10:44:00-04:00,WST,neutral
1370320.0,Stocks That Hit 52-Week Highs On Friday,2020-05-15 10:33:00-04:00,WST,neutral
1370321.0,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",2020-05-13 07:40:00-04:00,WST,neutral
1370322.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-12 10:41:00-04:00,WST,neutral
1370323.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,WST,negative
1370324.0,Stocks That Hit 52-Week Highs On Monday,2020-05-11 10:28:00-04:00,WST,neutral
1370325.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,WST,positive
1370326.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-28 10:18:00-04:00,WST,neutral
1370327.0,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",2020-04-28 07:36:00-04:00,WST,neutral
1370328.0,Stocks That Hit 52-Week Highs On Monday,2020-04-27 10:21:00-04:00,WST,neutral
1370329.0,Stocks That Hit 52-Week Highs On Friday,2020-04-24 10:33:00-04:00,WST,neutral
1370330.0,"Benzinga's Top Upgrades, Downgrades For April 24, 2020",2020-04-24 09:38:00-04:00,WST,positive
1370331.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,WST,positive
1370332.0,B of A Securities Upgrades West Pharmaceutical Servs to Neutral,2020-04-24 07:17:00-04:00,WST,positive
1370333.0,Why West Pharmaceutical Stock Is Trading Higher Today,2020-04-23 15:08:00-04:00,WST,neutral
1370334.0,West Pharmaceutical Services shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-04-23 13:04:00-04:00,WST,positive
1370335.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-23 10:41:00-04:00,WST,neutral
1370336.0,"The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt",2020-04-23 07:53:00-04:00,WST,negative
1370337.0,"West Pharmaceutical Servs Q1 Adj. EPS $1.010 Beats $0.820 Estimate, Sales $491.500M Beat $466.790M Estimate",2020-04-23 06:01:00-04:00,WST,neutral
1370338.0,"The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision",2020-04-19 17:22:00-04:00,WST,positive
1370339.0,Shares of several healthcare companies are trading higher as the market rebounds on extended measures to help curb the coronavirus. NOTE: The sector could also be trading higher due to increased demand for medical products amid the coronavirus outbreak.,2020-03-30 10:17:00-04:00,WST,positive
1370340.0,"Shares of several healthcare companies are trading lower as the coronavirus outbreak continues to cause economic disruption around the globe, leading to a steep selloff in equities across sectors.",2020-03-16 10:50:00-04:00,WST,negative
1370341.0,Afternoon Market Stats In 5 Minutes,2020-03-11 15:28:00-04:00,WST,neutral
1370342.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-19 10:32:00-05:00,WST,neutral
1370343.0,Stocks That Hit 52-Week Highs On Friday,2020-02-14 10:15:00-05:00,WST,neutral
1370344.0,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",2020-02-14 08:23:00-05:00,WST,negative
1370345.0,Stocks That Hit 52-Week Highs On Thursday,2020-02-13 10:26:00-05:00,WST,neutral
1370346.0,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO",2020-02-13 08:05:00-05:00,WST,negative
1370347.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-12 11:45:00-05:00,WST,neutral
1370348.0,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",2020-02-12 09:18:00-05:00,WST,positive
1370349.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-11 10:17:00-05:00,WST,neutral
1370350.0,The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight,2020-02-09 15:22:00-05:00,WST,neutral
1370351.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,WST,neutral
1370352.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-04 10:18:00-05:00,WST,neutral
1370353.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,WST,positive
1370354.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,WST,neutral
1370355.0,"The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics",2020-01-16 07:22:00-05:00,WST,neutral
1370356.0,"The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance",2020-01-15 08:22:00-05:00,WST,negative
1370357.0,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",2020-01-14 07:55:00-05:00,WST,positive
1370358.0,"The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger",2020-01-03 07:55:00-05:00,WST,negative
1370359.0,West  Announces 848K Share Buyback,2019-12-13 17:01:00-05:00,WST,positive
1370360.0,Bank of America Downgrades West Pharmaceutical Servs to Underperform,2019-12-12 07:21:00-05:00,WST,neutral
1370361.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,WST,neutral
1370362.0,West Pharma Reports Raised Minority Stake In Daikyo Seiko to 49%,2019-10-16 08:13:00-04:00,WST,neutral
1370363.0,Stocks That Hit 52-Week Highs On Friday,2019-09-06 12:23:00-04:00,WST,neutral
1370364.0,"The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication",2019-09-06 07:27:00-04:00,WST,neutral
1370365.0,Stocks That Hit 52-Week Highs On Thursday,2019-09-05 12:29:00-04:00,WST,neutral
1370366.0,"The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug",2019-09-05 08:12:00-04:00,WST,neutral
1370367.0,Stocks That Hit 52-Week Highs On Thursday,2019-08-29 10:15:00-04:00,WST,neutral
1370368.0,Stocks That Hit 52-Week Highs On Thursday,2019-08-22 10:32:00-04:00,WST,neutral
1370369.0,"The Daily Biotech Pulse: FDA Likes Nabriva's Antibiotic, Snubs Sarepta's DMD Drug; Moderna Gets Fast Track Designation For Zika Vaccine",2019-08-20 07:33:00-04:00,WST,negative
1370370.0,Stocks That Hit 52-Week Highs On Monday,2019-08-19 10:53:00-04:00,WST,neutral
1370371.0,"The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering",2019-08-14 07:50:00-04:00,WST,negative
1370372.0,A List Of Stocks Reaching New 52-Week Highs,2019-08-09 10:29:00-04:00,WST,positive
1370373.0,"The Daily Biotech Pulse: Vascepa Delay Sends Amarin Reeling, Eidos Jumps On Buyout Offer, Nektar's Bitter Q2",2019-08-09 07:19:00-04:00,WST,negative
1370374.0,Stocks That Set New 52-Week Highs Thursday,2019-08-08 12:19:00-04:00,WST,neutral
1370375.0,"The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering",2019-08-08 07:11:00-04:00,WST,neutral
1370376.0,Companies That Achieved 52-Week Highs Friday,2019-07-26 15:37:00-04:00,WST,neutral
1370377.0,Bank of America Upgrades West Pharmaceutical Servs to Neutral,2019-07-26 08:03:00-04:00,WST,neutral
1370378.0,"The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint",2019-07-26 07:26:00-04:00,WST,neutral
1370379.0,West Pharmaceutical Services shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 EPS and sales guidance.,2019-07-25 10:41:00-04:00,WST,positive
1370380.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,WST,negative
1370381.0,West Pharmaceutical Servs Raises FY2019 EPS Guidance from $2.8-2.9 to $3-3.1 vs $2.89 Est; Raises FY2019 Sales Guidance from $1.795B-1.82B to $1.81B-1.825B vs $1.81B Est,2019-07-25 06:16:00-04:00,WST,neutral
1370382.0,"West Pharmaceutical Servs Q2 EPS $0.89 Beats $0.72 Estimate, Sales $469.7M Beat $460.4M Estimate",2019-07-25 06:16:00-04:00,WST,neutral
1370383.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,WST,neutral
1370384.0,"Jefferies Downgrades West Pharmaceutical Services, Inc. Common Stock to Hold",2019-05-01 07:49:00-04:00,WST,neutral
1370385.0,"West Pharmaceutical Raises FY19 Adj. EPS From $2.77-$2.89 To $2.80-$2.90 vs $2.86 Est., Sees Sales $1.795B-$1.820B vs $1.81B Est.",2019-04-25 06:04:00-04:00,WST,neutral
1370386.0,"West Pharmaceutical Q1 Adj.  EPS $0.74 Beats $0.66 Estimate, Sales $443.5M Beat $433.37M Estimate",2019-04-25 06:03:00-04:00,WST,neutral
1370387.0,"Benzinga's Top Upgrades, Downgrades For April 23, 2019",2019-04-23 09:10:00-04:00,WST,positive
1370388.0,"William Blair Initiates Coverage On West Pharmaceutical Services, Inc. Common Stock with Outperform Rating",2019-04-23 08:27:00-04:00,WST,neutral
1370389.0,West Pharma Services Reports 800K Share Buyback,2019-02-21 06:16:00-05:00,WST,positive
1370390.0,"West Pharma Reaffirms FY18 Adj. EPS, Sales Guidance",2018-10-25 07:37:00-04:00,WST,neutral
1370391.0,"West Pharmaceutical Services, Inc. Q3 EPS $0.76 Beats $0.70 Estimate, Sales $431.7M Beat $428.4M Estimate",2018-10-25 07:37:00-04:00,WST,neutral
1370392.0,West Pharmaceutical Services CutsFY18 Capital Spending Guidance From $1.20M-$1.30M To $1.10M-$1.20M,2018-10-25 06:22:00-04:00,WST,neutral
1370393.0,"West Pharmaceutical Services Reaffirms FY18 Guidance; Sees Adj. EPS $2.80-$.90 vs $2.82 Est., Sales $1.72B-$1.73B vs $1.73B Est.",2018-10-25 06:22:00-04:00,WST,neutral
1370394.0,"West Pharmaceutical Services, Inc. Q3 Adj. EPS $0.76 Beats $0.70 Estimate, Sales $431.7M Beat $428.4M Estimate",2018-10-25 06:20:00-04:00,WST,neutral
1370395.0,"Stocks That Will Be Trading Ex Dividend For Tues., Oct. 23, 2018",2018-10-22 11:59:00-04:00,WST,neutral
1370396.0,"Stocks Which Set New 52-Week High Yesterday, October 1st",2018-10-02 09:20:00-04:00,WST,neutral
1370397.0,"Stocks Which Set New 52-Week High Yesterday, September 24th",2018-09-25 09:06:00-04:00,WST,neutral
1370398.0,"Stocks Which Set New 52-Week High Yesterday, September 20th",2018-09-21 08:16:00-04:00,WST,neutral
1370399.0,"Stocks Which Set New 52-Week High Friday, September 14th",2018-09-17 09:28:00-04:00,WST,neutral
1370400.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,WST,neutral
1370401.0,"Stocks Which Set New 52-Week High Yesterday, August 28th",2018-08-29 11:13:00-04:00,WST,neutral
1370402.0,"Stocks Which Set New 52-Week High Yesterday, August 14th",2018-08-15 12:29:00-04:00,WST,neutral
1370403.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,WST,neutral
1370404.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,WST,neutral
1370405.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,WST,neutral
1370406.0,"Stocks Which Set New 52-Week High Yesterday, August 2nd",2018-08-03 11:16:00-04:00,WST,neutral
1370407.0,"Stocks Which Set New 52-Week High Yesterday, July 26th:",2018-07-27 10:42:00-04:00,WST,neutral
1370408.0,"West Reaffirms FY18 Sales Guidance Of $1.72-$1.73B vs $1.73B Est., EPS $2.80-$2.90 vs $2.81 Est.",2018-07-26 06:10:00-04:00,WST,neutral
1370409.0,"West Pharmaceutical Servs Q2 EPS $0.70 Beats $0.67 Estimate, Sales $447.5M Beat $425.68M Estimate",2018-07-26 06:10:00-04:00,WST,neutral
1370410.0,"Jim Cramer Gives His Opinion On Cigna, VMware, WWE And More",2018-07-13 07:52:00-04:00,WST,neutral
1370411.0,4 Stocks That Have Been On Strong Up Trends In June,2018-06-25 16:32:00-04:00,WST,positive
1370412.0,West Pharmaceutical Services Appoints Bernard Birkett To Chief Financial Officer,2018-06-21 06:06:00-04:00,WST,neutral
1370413.0,West Pharmaceutical Services Raises Qtr Dividend From $0.14 to $0.15/Share,2018-05-03 06:15:00-04:00,WST,neutral
1370414.0,Bank of America Downgrades West Pharmaceutical Servs to Underperform,2018-04-25 09:26:00-04:00,WST,neutral
1370415.0,West Pharmaceutical Services CFO to Retire,2018-03-02 06:10:00-05:00,WST,neutral
1370416.0,West Pharma Services Sees FY18 Adj. EPS $2.80-$2.90 vs $2.90 Est.,2018-02-15 06:17:00-05:00,WST,neutral
1370417.0,"West Pharma Services Reports Q4 Adj. EPS $0.64 vs $0.63 Est., Sales $415.6M vs $416.6M Est.",2018-02-15 06:16:00-05:00,WST,neutral
1370418.0,"Goldman Sachs Initiates Coverage On West Pharmaceutical Servs with Neutral Rating, Announces $110.00 Price Target",2018-01-24 08:28:00-05:00,WST,neutral
1370419.0,"West Pharma Services Raises FY17 Guidance: Adj. EPS From $2.66-$2.73 To $2.74-$2.79 vs $2.67 Est., Sales From $1.585B-$1.6B To $1.595B-$1.605B vs $1.59B Est.",2017-10-26 07:14:00-04:00,WST,neutral
1370420.0,"West Pharma Services Reports Q3 EPS $0.67 vs $0.53 Est., Sales $398.2M vs $385.9M Est.",2017-10-26 07:13:00-04:00,WST,neutral
1370421.0,Bank of America Downgrades West Pharmaceutical Servs to Neutral,2017-10-17 09:30:00-04:00,WST,neutral
1370422.0,"Benzinga's Top Upgrades, Downgrades For October 3, 2017",2017-10-03 10:19:00-04:00,WST,positive
1370423.0,"Stephens & Co. Initiates Coverage On West Pharmaceutical Servs with Equal-Weight Rating, Announces $99.00 Price Target",2017-10-03 07:17:00-04:00,WST,neutral
1370424.0,"Benzinga's Top Upgrades, Downgrades For September 15, 2017",2017-09-15 09:29:00-04:00,WST,positive
1370425.0,The Market In 5 Minutes,2017-09-15 08:37:00-04:00,WST,neutral
1370426.0,"Jefferies Upgrades West Pharmaceutical Servs to Buy, Announces $115.00 Price Target",2017-09-15 06:35:00-04:00,WST,neutral
1370427.0,"West Pharma Services Narrows FY17 Outlook: EPS From $2.66-$2.78 To $2.66-$2.73 vs $2.73 Est., Sales $1.585B-$1.61B To $1.585B-$1.6B vs $1.61B Est.",2017-07-27 06:26:00-04:00,WST,neutral
1370428.0,"West Pharma Services Reports Q2 Adj. EPS $0.66 vs $0.65 Est., Sales $397.6M vs $406M Est.",2017-07-27 06:25:00-04:00,WST,neutral
1370429.0,West Pharma Services Raises Qtr. Dividend From $0.13 To $0.14/Share,2017-07-20 06:22:00-04:00,WST,neutral
1370430.0,"West Pharma Services Raises EPS Outlook: from $2.45-$2.57 to $2.66-$2.78 vs $2.50 Est., Sales $1.585B-$1.61B vs $1.6B Est.",2017-04-27 07:19:00-04:00,WST,neutral
1370431.0,"West Pharma Services Reports Q1 Adj. EPS $0.53 vs $0.55 Est., Sales $387.7M vs $380.4M Est.",2017-04-27 07:18:00-04:00,WST,neutral
1370432.0,"West Sees FY17 Rev. $1.585-$1.61B vs. $1.62B Est., EPS $2.45-$2.57 vs. $2.57 Est.",2017-02-16 07:03:00-05:00,WST,neutral
1370433.0,"West Reports Q4 Adj. EPS $0.54 vs. $0.56, Rev. $382.3M vs. $387M Est.",2017-02-16 07:02:00-05:00,WST,neutral
1370434.0,West Pharma Announces 800K Share Buyback,2016-12-14 07:03:00-05:00,WST,positive
1370435.0,"West Sees FY17 Organic Rev. Growth Of 6-8%, Reaffirming 2020 Rev. Target Of $2.2-$2.4B",2016-10-27 07:12:00-04:00,WST,positive
1370436.0,"West Sees FY16 Rev. $1.505-$1.52B vs. Est. $1.51B, EPS Narrowed From $2.15-$2.25 To $2.17-$2.22",2016-10-27 07:11:00-04:00,WST,neutral
1370437.0,"West Reports Q3 EPS $0.53 vs. Est. $0.53, Rev. $376.7M vs. Est. $371.2M",2016-10-27 07:10:00-04:00,WST,neutral
1370438.0,"5 Notable Stocks Trading Ex-Dividend Monday, October 17",2016-10-14 12:15:00-04:00,WST,neutral
1370439.0,Mid-Afternoon Market Update: Dow Surges 125 Points; FedEx Shares Jump Following Upbeat Earnings,2016-09-21 15:26:00-04:00,WST,positive
1370440.0,12 Biggest Mid-Day Losers For Wednesday,2016-09-21 13:03:00-04:00,WST,negative
1370441.0,Mid-Morning Market Update: Markets Open Higher; General Mills Earnings Top Views,2016-09-21 10:05:00-04:00,WST,positive
1370442.0,Wells Fargo Downgrades West Pharmaceutical Servs to Market Perform,2016-09-21 07:36:00-04:00,WST,positive
1370443.0,Wells Fargo Downgrades West Pharmaceutical Servs to Market Perform,2016-09-21 07:35:00-04:00,WST,positive
1370444.0,West Pharmaceutical Increases Qtr Dividend From $0.12 to $0.13/Share,2016-09-12 07:09:00-04:00,WST,neutral
1370445.0,"West Raises FY16 Guidance From $1.49-$1.51B To $1.505-$1.52B, EPS From $2.12-$2.25 To $2.15-$2.25",2016-07-28 07:03:00-04:00,WST,neutral
1370446.0,"West reports Q2 EPS $0.59 vs. Est. $0.56, Rev. $388M vs. Est. $384M",2016-07-28 07:02:00-04:00,WST,neutral
1370447.0,"West Sees FY16 Rev. $1.49-$1.51B vs. Est. $1.5B, EPS $2.12-$2.25 vs. Est. $2.18",2016-04-28 07:05:00-04:00,WST,neutral
1370448.0,"Weste Reports Q1 EPS $0.53 vs. Est. $0.51, Rev. $362.1M vs. Est. $356M",2016-04-28 07:04:00-04:00,WST,neutral
1370449.0,Benzinga's Top Initiations,2016-03-22 09:10:00-04:00,WST,positive
1370450.0,Wells Fargo Initiates Coverage on West Pharmaceutical Servs at Outperform,2016-03-22 06:53:00-04:00,WST,positive
1370451.0,West Names Eric Resnick to Chief Technology Officer,2016-03-01 07:05:00-05:00,WST,neutral
1370452.0,"West Reports Q4 EPS $0.47, Rev. $359.7M",2016-02-18 07:01:00-05:00,WST,neutral
1370453.0,"West Reports New Organizational Structure, Names Chief Commercial Officer",2016-01-12 07:05:00-05:00,WST,neutral
1370454.0,West Reports 700K Share Buyback,2015-12-17 08:00:00-05:00,WST,positive
1370455.0,"West Pharma Reports Q3 Adj EPS $0.44 Vs Est $0.43, Sales $344.5M Vs Est $353.27M, Raises 2015 Adj EPS $1.79-$1.84 & Revs To Grow 6%-8%",2015-10-29 07:14:00-04:00,WST,neutral
1370456.0,West Raises Qtr. Dividend from $0.11 to $0.12/Share,2015-07-14 16:30:00-04:00,WST,neutral
1370457.0,"West Pharma Srvcs Reports Q1 EPS $0.45 Vs Est $0.40, Sales 335.9M Vs Est $346.64, Narrows FY EPS $1.69-$1.84 & Revs $1.40B-$1.43",2015-04-30 07:22:00-04:00,WST,neutral
1370458.0,West Pharmaceutical Services Names Eric Green CEO,2015-04-15 07:03:00-04:00,WST,neutral
1370459.0,"West Q4. Announces EPS. $0.45, Rev. $349.8M",2015-02-19 07:08:00-05:00,WST,neutral
1370460.0,West Pharmaceutical Services Says 2019 Revenue Goal in Range of $2.1B-$2.3B,2015-01-14 06:57:00-05:00,WST,neutral
1370461.0,West Pharmaceutical Services Expects 2015 Sales Growth to be in 5%-8% Range,2015-01-14 06:54:00-05:00,WST,positive
1370462.0,West Provides Required Notice Of Automatic Conversion Of Debentures,2014-12-01 16:33:00-05:00,WST,neutral
1370463.0,West Receives 510(k) Clearance For NovaGuard SA Safety System,2014-11-11 08:06:00-05:00,WST,positive
1370464.0,"West Pharmaceutical Services, Inc. Reports Q3 EPS of $0.44 vs $0.43 Est; Announces $100M Buyback Plan",2014-10-30 07:21:00-04:00,WST,neutral
1370465.0,West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark ,2014-10-21 08:11:00-04:00,WST,neutral
1370466.0,"West Pharmaceutical Services Warns On FY14, CEO To Retire",2014-10-15 10:23:00-04:00,WST,negative
1370467.0,"West Pharmaceutical Services, Inc. Narrows FY2014 EPS Guidance from $1.77-1.89 to $1.77-1.82 vs $1.84 Est",2014-10-15 08:23:00-04:00,WST,neutral
1370468.0,"West Pharmaceutical Services, Inc. Sees Q3 EPS $0.44 vs $0.43 Est",2014-10-15 08:23:00-04:00,WST,neutral
1370469.0,West Pharmaceutical Services Announces CEO Donald Morel To Retire; ,2014-10-15 08:23:00-04:00,WST,neutral
1370470.0,West to Open New Pharmaceutical Component Manufacturing Plant in Ireland ,2014-10-02 05:33:00-04:00,WST,neutral
1370471.0,"West Pharmaceutical Services, Inc. Reports Q2 EPS of $0.52 vs $0.47 Est",2014-07-31 07:14:00-04:00,WST,neutral
1370472.0,West Pharma Raises Qtr. Dividend from $0.10 to $0.11/Share,2014-07-16 16:45:00-04:00,WST,neutral
1370473.0,"West Pharmaceutical Services, Inc. Raises FY2014 EPS Guidance from $1.75-1.89 to $1.77-1.89 vs $1.82 Est; Sees Sales $1.45B-1.48B vs $1.46B Est",2014-05-01 07:27:00-04:00,WST,neutral
1370474.0,"West Pharmaceutical Services, Inc. Reports Q1 EPS of $0.38 vs $0.41 Est; Revenue of $346.80M vs $340.88M Est",2014-05-01 07:26:00-04:00,WST,neutral
1370475.0,"West Pharmaceutical Services, Inc. Reports Q4 EPS of $0.33 vs $0.38 Est; Revenue of $342.70M vs $348.70M Est",2014-02-20 07:09:00-05:00,WST,neutral
1370476.0,"West Pharmaceutical Services, Inc. Sees FY2013 EPS $1.58-1.63 vs $1.60 Est",2013-10-31 07:10:00-04:00,WST,neutral
1370477.0,"West Pharmaceutical Services, Inc. Reports Q3 EPS of $0.39 vs $0.36 Est",2013-10-31 07:10:00-04:00,WST,neutral
1370478.0,Stocks Hitting 52-Week Highs,2013-10-09 10:14:00-04:00,WST,neutral
1370479.0,UPDATE: Bank of America Initiates Coverage on West Pharmaceutical Services Ahead of Multiple Delivery System Launches,2013-10-08 10:28:00-04:00,WST,neutral
1370480.0,"Bank of America Initiates Coverage on West Pharmaceutical Services, Inc. at Buy, Announces $50.00 PO",2013-10-08 06:11:00-04:00,WST,negative
1370481.0,Stocks Hitting 52-Week Lows,2013-09-30 10:32:00-04:00,WST,negative
1370482.0,"West Pharmaceutical Services, Inc. Reports Q2 EPS of $0.86 vs $0.82 Est; Revenue of $344.50M vs $349.85M Est",2013-08-01 07:50:00-04:00,WST,neutral
1370483.0,"West Pharmaceutical Services, Inc. Reports Q2 EPS of $0.86 vs $0.82 Est; Revenue of $344.50M vs $349.85M Est",2013-08-01 07:49:00-04:00,WST,neutral
1370484.0,NASDAQ Says Will Cancel Some Trades in WST,2013-05-02 10:17:00-04:00,WST,negative
1370485.0,NASDAQ Probing Potentially Erroneous Transactions in WST Between 9:30-9:34AM EDT,2013-05-02 09:58:00-04:00,WST,negative
1370486.0,"UPDATE: Jefferies Reiterates Hold Rating, Raises PT on West Pharmaceutical Services on 4Q12 EPS",2013-02-22 11:05:00-05:00,WST,neutral
1370487.0,"Jefferies Maintains Hold on West Pharmaceutical Services, Inc., Raises PT to $56.00",2013-02-22 07:55:00-05:00,WST,neutral
1370488.0,Insider Buying in West Pharmaceutical on February 19 - SEC Form 4 Filings,2013-02-21 11:46:00-05:00,WST,neutral
1370489.0,"UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on West Pharmaceutical Services",2012-11-05 09:59:00-05:00,WST,neutral
1370490.0,"Jefferies & Company Maintains West Pharmaceutical Services at Hold, Raises PT from $45 to $49",2012-11-05 07:55:00-05:00,WST,neutral
1370491.0,West Pharmaceutical Services Reports Q3 EPS $0.52 vs $0.50 Est; Revenues $303.8M vs $306.91M Est,2012-11-01 09:27:00-04:00,WST,neutral
1370492.0,West Pharma Boosts Dividend to $0.19 from $0.18,2012-10-01 16:39:00-04:00,WST,positive
1370493.0,West Announces Commercial Launch of B.safe Syringe,2012-09-11 08:09:00-04:00,WST,neutral
1370494.0,West Pharmaceutical Services Reports Q2 EPS $0.79 vs $0.69 Est; Revenues $324.8M vs $321.50M Est,2012-08-02 08:39:00-04:00,WST,neutral
1370495.0,West Pharmaceutical Services Reports Q2 EPS $0.79 vs $0.69 Est; Revenues $324.8M vs $321.50M Est,2012-08-02 07:10:00-04:00,WST,neutral
1370496.0,West Announces Technology Agreement With Amgen  ,2012-06-20 16:31:00-04:00,WST,positive
1370497.0,West Announces Proposed Private Placement of Senior Debt Securities  ,2012-05-08 08:31:00-04:00,WST,negative
1370498.0,West Announces Commencement of Cash Tender Offer for Any and All of Its 4.00% Convertible Junior Subordinated Debentures Due 2047  ,2012-05-08 08:31:00-04:00,WST,neutral
1370499.0,"Jefferies & Company Maintains West Pharmaceutical Services at Hold, Raises PT from $41 to $43",2012-04-27 07:09:00-04:00,WST,neutral
1370500.0,West Pharmaceutical Services Reports Q1 EPS $0.83 vs $0.66 Est; Revenues $316.3M vs $308.20M Est,2012-04-26 07:06:00-04:00,WST,neutral
1370501.0,West Pharmaceutical Services up 10.5% on Q1 Outlook ,2012-04-17 12:49:00-04:00,WST,neutral
1370502.0,West Pharma Pre-Announces Q1 EPS $0.81 vs $0.65 Est; 2012 Guidance to $2.37-$2.55 vs $2.47 Est,2012-04-17 07:03:00-04:00,WST,neutral
1370503.0,West Pharmaceutical Services Reports Q4 EPS $0.59 vs $0.55 Est,2012-02-16 07:03:00-05:00,WST,neutral
1370504.0,West Pharmaceutical Services Reports Q3 EPS $0.53 vs $0.52 Est; Revenues $293.6M vs $289.25M Est	,2011-11-01 07:01:00-04:00,WST,neutral
1370505.0,West Increases Dividend to $0.18,2011-10-07 16:30:00-04:00,WST,neutral
1370506.0,West Pharmaceutical Services Reports Q2 EPS $0.62 vs $0.67 Est; Revenues $307.9M vs $299.45M Est ,2011-07-28 08:46:00-04:00,WST,neutral
1370507.0,"Companies Going Ex-Dividend include Caterpillar, Lowes, WGL Holdings, and West Pharma",2011-07-18 08:35:00-04:00,WST,neutral
1370508.0,"News Summary for July 18, 2011",2011-07-18 07:54:00-04:00,WST,neutral
1370509.0,Jefferies Raises PT On West Pharmaceutical To $45,2011-04-29 07:05:00-04:00,WST,neutral
1370510.0,West Pharma Guides 2011 EPS $2.21-$2.42 (WST),2011-04-28 09:16:00-04:00,WST,neutral
1370511.0,West Pharma Services Reports EPS of $0.60 vs. $0.62 Estimate; Revenues $295.4M vs. $291.97M Estimate,2011-04-28 07:23:00-04:00,WST,neutral
1370512.0,"Investing for the Diabetes Epidemic (DVA, FMS, WST, BDX, RVP)",2011-04-11 18:35:00-04:00,WST,neutral
1370513.0,West and CareFusion Announce Plans to Develop a Needle-Free Vented Vial Access Device   ,2011-03-24 08:08:00-04:00,WST,neutral
1370514.0,Jefferies Downs WST To Hold,2011-02-18 06:47:00-05:00,WST,neutral
1370515.0,Bearish MACD for West Pharma - Tale of the Tape,2011-01-25 11:31:00-05:00,WST,neutral
1370516.0,Bearish MACD for West Pharma - Tale of the Tape,2011-01-25 10:59:00-05:00,WST,neutral
1370517.0,West Pharmaceutical Names New President of Pharmaceutical Packaging Systems  ,2011-01-05 08:39:00-05:00,WST,neutral
1370518.0,West Announces Dividend of $.17,2010-12-16 16:29:00-05:00,WST,neutral
1370519.0,West Pharmaceuticals to Consolidate Certain Operations ,2010-12-07 08:07:00-05:00,WST,positive
1370520.0,West Increases Quarterly Dividend to $0.17,2010-10-04 16:17:00-04:00,WST,neutral
